Last reviewed · How we verify
Control primer
At a glance
| Generic name | Control primer |
|---|---|
| Also known as | TransbondTM XT orthodontic primer |
| Sponsor | University of Baghdad |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Performance of a Novel Self-cured Resin Composite Compared to a Light-cured Bioactive Resin Composite Restoration in Proximal Cavities of Posterior Teeth (EARLY_PHASE1)
- Two-Year Clinical Performance of Self-Cured Resin Composite in Comparison to Light-Cured Bioactive Resin Composite in Restoring Occlusal Cavities of Posterior Teeth. (NA)
- Evaluation of Mandibular Posterior Zirconia Crowns With Different Ti-Base Surface Treatments. (NA)
- Clinical Performance of an Innovative Self-cure Bulk-Fill Composite Compared to Dual-Cure and Light-Cure Bulk-Fill Composite in Posterior Restorations. (NA)
- Clinical Performance of Bioactive Restorative Materials (NA)
- Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients (NA)
- Comparison of a 3-step Bonding System (Transbond™ XT) and a 2-step System (GC Ortho Connect™) on Demineralization Around Maxillary Orthodontic Brackets (NA)
- Miro-randomized Trial for Optimizing a JITAI to Reduce Dietary Lapses in Obesity Treatment (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |